Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific
Shohei Kimura1, Nobuharu Tamaki1, Mayu Higuchi1
1Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino-shi, Tokyo 180-8610, Japan.
Insights
The FIB-3 index shows similar accuracy to the FIB-4 index for detecting liver fibrosis but performs more consistently across all age groups, making it a potentially better alternative for older adults.
Area of Science:
- Hepatology
- Medical Diagnostics
- Biomarkers
Background:
- Chronic liver diseases are prevalent, necessitating non-invasive fibrosis assessment.
- The widely used FIB-4 index's age-dependency may limit its specificity in elderly patients.
- The FIB-3 index, excluding age, is a proposed alternative for liver fibrosis detection.
Purpose of the Study:
- To compare the diagnostic performance of FIB-3 and FIB-4 indices for advanced liver fibrosis.
- To evaluate index performance across different age groups.
- To utilize magnetic resonance elastography (MRE) as the gold standard for fibrosis assessment.
Main Methods:
- Retrospective analysis of 3424 chronic liver disease patients (age ≥30) who underwent MRE.
- Advanced fibrosis defined as liver stiffness ≥ 3.62 kPa.
- Diagnostic performance and cutoff values of FIB-3 and FIB-4 evaluated in age-stratified subgroups; AUROCs compared using DeLong's test.
Main Results:
- Both FIB-3 and FIB-4 indices showed comparable diagnostic accuracy for advanced fibrosis (AUROC 0.82).
- FIB-4 index cutoff values increased significantly with age across quartiles.
- FIB-3 index exhibited less variation in cutoff values across age quartiles, indicating more consistent performance.
Conclusions:
- FIB-3 index provides diagnostic accuracy similar to FIB-4 for advanced liver fibrosis.
- FIB-3 demonstrates more consistent performance across diverse age groups compared to FIB-4.
- FIB-3 index is a valuable alternative, especially for older populations where FIB-4 may be less reliable due to age-related factors.
Abstract:
Background and Aims: Given the high prevalence of chronic liver diseases, non-invasive assessment of liver fibrosis is critical for screening and management of these conditions. While the FIB-4 index is widely used, its age-dependent nature may reduce specificity in older adults. The FIB-3 index, which excludes age, has been proposed as an alternative. This study aimed to compare the diagnostic performance of FIB-3 and FIB-4 for detecting advanced fibrosis across age groups using magnetic resonance elastography (MRE) as the reference standard. Methods: We retrospectively analyzed 3424 patients aged ≥30 years with chronic liver disease who underwent MRE. Advanced fibrosis was defined as liver stiffness ≥ 3.62 kPa. The cutoff values and diagnostic performance of the FIB-4 and FIB-3 indices for advanced fibrosis were evaluated within subgroups stratified by age quartiles (Q1-Q4), and the areas under the ROC curves (AUROCs) were compared using DeLong's test. Results: Both FIB-3 and FIB-4 indices demonstrated comparable diagnostic accuracy for advanced fibrosis (AUROC 0.82 (95% CI: 0.81-0.83) for both; p = 0.70). In age-stratified analysis, the cutoff values for the FIB-4 index increased with increasing age (Q1: 1.72, Q2: 2.90, Q3: 3.66, Q4: 4.20), reflecting its age-dependent formula. In contrast, the FIB-3 index exhibited relatively minor variation in cutoff values across quartiles (Q1: 2.32, Q2: 3.52, Q3: 3.74, Q4: 3.14). Conclusions: FIB-3 index offers similar diagnostic accuracy to FIB-4 index while demonstrating more consistent performance across age groups. These findings provide evidence that FIB-3 index may be a useful alternative, particularly in older populations where FIB-4 index interpretation may be confounded by age.
More Related Videos
10:10Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
Published on: July 20, 2022
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow